Title : Lestaurtinib potentiates TRAIL-induced apoptosis in glioma via CHOP-dependent DR5 induction.

Pub. Date : 2020 Jul

PMID : 32441887






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Lestaurtinib, also called CEP-701, is an inhibitor of tyrosine kinase, causes haematological remission in patients with AML possessing FLT3-ITD (FLT3 gene) internal tandem duplication and strongly inhibits tyrosine kinase FLT3. lestaurtinib fms related receptor tyrosine kinase 3 Homo sapiens
2 Lestaurtinib, also called CEP-701, is an inhibitor of tyrosine kinase, causes haematological remission in patients with AML possessing FLT3-ITD (FLT3 gene) internal tandem duplication and strongly inhibits tyrosine kinase FLT3. lestaurtinib fms related receptor tyrosine kinase 3 Homo sapiens
3 Lestaurtinib, also called CEP-701, is an inhibitor of tyrosine kinase, causes haematological remission in patients with AML possessing FLT3-ITD (FLT3 gene) internal tandem duplication and strongly inhibits tyrosine kinase FLT3. lestaurtinib fms related receptor tyrosine kinase 3 Homo sapiens
4 Lestaurtinib, also called CEP-701, is an inhibitor of tyrosine kinase, causes haematological remission in patients with AML possessing FLT3-ITD (FLT3 gene) internal tandem duplication and strongly inhibits tyrosine kinase FLT3. lestaurtinib fms related receptor tyrosine kinase 3 Homo sapiens
5 Lestaurtinib, also called CEP-701, is an inhibitor of tyrosine kinase, causes haematological remission in patients with AML possessing FLT3-ITD (FLT3 gene) internal tandem duplication and strongly inhibits tyrosine kinase FLT3. lestaurtinib fms related receptor tyrosine kinase 3 Homo sapiens
6 Lestaurtinib, also called CEP-701, is an inhibitor of tyrosine kinase, causes haematological remission in patients with AML possessing FLT3-ITD (FLT3 gene) internal tandem duplication and strongly inhibits tyrosine kinase FLT3. lestaurtinib fms related receptor tyrosine kinase 3 Homo sapiens